Literature DB >> 21155185

The role of inflammation in the pathogenesis of non-small cell lung cancer.

Dermot S O'Callaghan1, Dearbhaile O'Donnell, Finbarr O'Connell, Kenneth J O'Byrne.   

Abstract

The link between chronic immune activation and tumorigenesis is well established. Compelling evidence has accumulated that histologic assessment of infiltration patterns of different host immune response components in non-small cell lung cancer specimens helps identify different prognostic patient subgroups. This review provides an overview of recent insights gained in the understanding of the role played by chronic inflammation in lung carcinogenesis. The usefulness of quantification of different populations of lymphocytes, natural killer cells, macrophages, and mast cells within the tumor microenvironment in non-small cell lung cancer is also discussed. In particular, the importance of assessment of inflammatory cell microlocalization within both the tumor islet and surrounding stromal components is emphasized.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21155185     DOI: 10.1097/jto.0b013e3181f387e4

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  105 in total

1.  Pleural Neutrophil-to-Lymphocyte Ratio May Be Associated With Early Disease Progression in Stage IV Non-small Cell Lung Cancer.

Authors:  Jeong Uk Lim; Chang Dong Yeo; Hyung Woo Kim; Hye Seon Kang; Chan Kwon Park; Ju Sang Kim; Jin Woo Kim; Seung Joon Kim; Sang Haak Lee
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Cisplatin or carboplatin? Neutrophil to lymphocyte ratio may serve as a useful factor in small cell lung cancer therapy selection.

Authors:  Zhangchi Pan; Lu Zhang; Chen Liu; Xiaobing Huang; Songfei Shen; Xiaoyan Lin; Chunmei Shi
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

3.  Neutrophil to lymphocyte ratio associated with prognosis of lung cancer.

Authors:  V Bar-Ad; J Palmer; L Li; Y Lai; B Lu; R E Myers; Z Ye; R Axelrod; J M Johnson; M Werner-Wasik; S W Cowan; N R Evans; B T Hehn; C C Solomides; C Wang
Journal:  Clin Transl Oncol       Date:  2016-12-01       Impact factor: 3.405

4.  Can we use interleukin-1β blockade for lung cancer treatment?

Authors:  Adrian Gottschlich; Stefan Endres; Sebastian Kobold
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 5.  The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.

Authors:  Tristan Tham; Caitlin Olson; Julian Khaymovich; Saori Wendy Herman; Peter David Costantino
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-13       Impact factor: 2.503

6.  Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls.

Authors:  Gianluigi Mazzoccoli; Robert B Sothern; Paola Parrella; Lucia A Muscarella; Vito Michele Fazio; Francesco Giuliani; Victoria Polyakova; Igor M Kvetnoy
Journal:  Clin Exp Med       Date:  2011-09-11       Impact factor: 3.984

7.  The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.

Authors:  Rihong Zhai; Xiaojin Yu; Andrea Shafer; John C Wain; David C Christiani
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

8.  Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice.

Authors:  Cheng-Hua Zhou; Ya-Ya Wan; Xiang-Hua Chu; Zheng Song; Shu-Hua Xing; Yu-Qing Wu; Xiao-Xing Yin
Journal:  Oncol Lett       Date:  2012-09-21       Impact factor: 2.967

9.  Neutrophil to lymphocyte and platelet to lymphocyte ratios increase in ovarian tumors in the presence of frank stromal invasion.

Authors:  M Polat; T Senol; E Ozkaya; G Ogurlu Pakay; M S Cikman; B Konukcu; M A Ozten; A Karateke
Journal:  Clin Transl Oncol       Date:  2015-08-20       Impact factor: 3.405

10.  Epidermal growth factor (EGF) regulates α5β1 integrin activation state in human cancer cell lines through the p90RSK-dependent phosphorylation of filamin A.

Authors:  Daniel Vial; Paula J McKeown-Longo
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.